• Paul G Van Buynder, Gillian Frosst, Jan L Van Buynder, Francios-William Tremblay, Alie Ross, Claire Jardine, and Bao Gang Fei.
• Fraser Health Authority, Surrey, British Columbia, Canada. pjvb@iinet.net.au
• Influenza Other Respi Viruses. 2013 Mar 1; 7 (2): 184-90.

BackgroundInfluenza in children causes significant morbidity and hospitalizations and also some mortality particularly in children < 5 years of age. Influenza vaccination in children has been shown to be safe and effective, but in 2010 the pediatric influenza vaccination program was suspended in Western Australia after the rate of febrile convulsions observed (9/1000 doses) was 55 times the previously reported rate. In 2009, over 80% of all children in New Brunswick were vaccinated with an adjuvanted monovalent H1N1 vaccine shown to have very high effectiveness, raising the prospect of potential hyper-responsiveness because of residual protection. We conducted enhanced post-marketing surveillance to monitor local and general reactions.MethodsParents of participating children seen at dedicated vaccination clinics were given influenza vaccine survey kits to record local and general symptoms up to 3 days following receipt of season influenza vaccine.ResultsFebrile reactions of ≥ 38° occurred in <10% of children who received a first dose of seasonal influenza vaccine (n = 660) and severe febrile incidents with fever ≥ 39° were uncommon. Concurrent administration of other vaccine(s) including conjugated pneumococcal vaccine appeared to increase reactogenicity. No child in the study had a febrile convulsion.Conclusion  Influenza vaccines in children are safe, and this study provides a baseline for rapid assessment studies at the start of a vaccine season. Parents should be aware of increased fevers with concurrent vaccine administration, and antipyretics should be considered.© 2012 Blackwell Publishing Ltd and Her Majesty the Queen in Right of Canada 2012. Reproduced with the permission of the Minister Health.

21 keywords...

hide…